New hope for managing troubling medication side effect
NCT ID NCT07386080
Summary
This study aims to find out if a drug called cabergoline is safe for treating high prolactin levels, a common side effect of antipsychotic medications in people with schizophrenia. Researchers want to see if taking cabergoline for 12 weeks worsens schizophrenia symptoms compared to a placebo. About 146 adults with schizophrenia who have this side effect will participate to help answer this question.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zealand University Hospital
Køge, Region Sjælland, 4600, Denmark
Conditions
Explore the condition pages connected to this study.